Skip to main content

MS Vision to Sell, Service Ionalytics Selectra Tech for ABI, MDS Proteomics Platform

NEW YORK, Nov. 19 (GenomeWeb News) - MS vision will serve as Ionalytics' European agent, providing sales and service support for the proteomics company's Selectra technology.

 

Under the agreement, MS Vision will market Ionalytics Selectra in Europefor the Applied Biosystems/MDS Sciex API 300, 365 and 3000.

 

According to Ionalytics, Selectra enhances mass-spectrometer performance by providing an additional dimension of ion separation. Based on FAIMS technology, the Selectra transmits a targeted subset of ions into a mass spectrometer, resulting in improved detection limits, increased selectivity and increased throughput.

 

Financial terms of the agreement were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.